> 0 1 0 1 O
70 1 3 1 3 B-lower_bound
( 4 5 4 5 O
see 5 8 5 8 O
Appendix 9 17 9 17 O
A 18 19 18 19 O
) 19 20 19 20 O
within 21 27 21 27 O
two 28 31 28 31 B-upper_bound
weeks 32 37 32 37 I-upper_bound
of 38 40 38 40 O
enrollment 41 51 41 51 O

A 0 1 52 53 O
measure 2 9 54 61 O
of 10 12 62 64 O
general 13 20 65 72 O
well 21 25 73 77 O
being 26 31 78 83 O
and 32 35 84 87 O
activities 36 46 88 98 O
of 47 49 99 101 O
daily 50 55 102 107 O
living 56 62 108 114 O
; 62 63 114 115 O
scores 64 70 116 122 O
range 71 76 123 128 O
from 77 81 129 133 O
0 82 83 134 135 B-lower_bound
to 84 86 136 138 O
100 87 90 139 142 B-upper_bound
where 91 96 143 148 O
100 97 100 149 152 O
represents 101 111 153 163 O
perfect 112 119 164 171 O
health 120 126 172 178 O
) 126 127 178 179 O

Documented 0 10 180 190 O
evidence 11 19 191 199 O
of 20 22 200 202 O
distant 23 30 203 210 B-cancer
metastases 31 41 211 221 I-cancer

EBV 0 3 222 225 B-chronic_disease
( 4 5 226 227 O
+ 5 6 227 228 O
) 6 7 228 229 O
Nasopharyngeal 8 22 230 244 O
Carcinoma 23 32 245 254 O
in 33 35 255 257 O
the 36 39 258 261 O
protocol 40 48 262 270 O
treated 49 56 271 278 O
tumor 57 62 279 284 B-cancer

Estimated 0 9 285 294 B-clinical_variable
Creatinine 10 20 295 305 I-clinical_variable
clearance 21 30 306 315 I-clinical_variable
> 31 32 316 317 O
30cc 32 36 317 321 B-lower_bound
/ 36 37 321 322 I-lower_bound
min 37 40 322 325 I-lower_bound

HPV(+ 0 5 326 331 B-chronic_disease
) 5 6 331 332 O
or 7 9 333 335 O
p16(+ 10 15 336 341 O
) 15 16 341 342 O
locally 17 24 343 350 O
/ 24 25 350 351 O
regionally 25 35 351 361 O
advanced 36 44 362 370 O
( 45 46 371 372 B-cancer
T4 46 48 372 374 I-cancer
or 49 51 375 377 I-cancer
N3 52 54 378 380 I-cancer
) 54 55 380 381 I-cancer
oropharyngeal 56 69 382 395 I-cancer
cancer 70 76 396 402 I-cancer

HPV(‐ 0 5 403 408 B-chronic_disease
) 5 6 408 409 O
( 7 8 410 411 O
Human 8 13 411 416 B-chronic_disease
Papillomavirus 14 28 417 431 I-chronic_disease
) 28 29 431 432 O
or 30 32 433 435 O
p16(- 33 38 436 441 O
) 38 39 441 442 O
locally 40 47 443 450 O
/ 47 48 450 451 O
regionally 48 58 451 461 O
advanced 59 67 462 470 O
( 68 69 471 472 B-cancer
T3‐4 69 73 472 476 I-cancer
or 74 76 477 479 I-cancer
N2‐3 77 81 480 484 I-cancer
) 81 82 484 485 I-cancer
oropharyngeal 83 96 486 499 I-cancer
cancer 97 103 500 506 I-cancer

Locally 0 7 507 514 O
/ 7 8 514 515 O
regionally 8 18 515 525 O
advanced 19 27 526 534 O
( 28 29 535 536 O
stage 29 34 536 541 B-cancer
T3‐4 35 39 542 546 I-cancer
and/or 40 46 547 553 O
N3 47 49 554 556 B-cancer
) 49 50 556 557 O
nasopharyngeal 51 65 558 572 B-cancer
cancer 66 72 573 579 I-cancer
which 73 78 580 585 O
is 79 81 586 588 O
EBV 82 85 589 592 B-chronic_disease
( 86 87 593 594 I-chronic_disease
‐ 87 88 594 595 I-chronic_disease
) 88 89 595 596 I-chronic_disease
( 90 91 597 598 I-chronic_disease
Epstein‐Barr 91 103 598 610 I-chronic_disease
Virus 104 109 611 616 I-chronic_disease
) 109 110 616 617 I-chronic_disease

Patients 0 8 618 626 O
are 9 12 627 630 O
adults 13 19 631 637 O
( 20 21 638 639 O
Age 21 24 639 642 B-age
> 25 26 643 644 O
18 26 28 644 646 B-lower_bound
) 28 29 646 647 O

Patients 0 8 648 656 O
must 9 13 657 661 O
be 14 16 662 664 O
able 17 21 665 669 O
to 22 24 670 672 O
receive 25 32 673 680 O
protocol 33 41 681 689 O
chemotherapy 42 54 690 702 B-treatment
in 55 57 703 705 O
the 58 61 706 709 O
judgment 62 70 710 718 O
of 71 73 719 721 O
the 74 77 722 725 O
treating 78 86 726 734 O
Medical 87 94 735 742 O
Oncologist 95 105 743 753 O

Patients 0 8 754 762 O
should 9 15 763 769 O
have 16 20 770 774 O
no 21 23 775 777 O
contraindications 24 41 778 795 O
to 42 44 796 798 O
having 45 51 799 805 O
a 52 53 806 807 O
contrast 54 62 808 816 O
enhanced 63 71 817 825 O
MRI 72 75 826 829 B-treatment
scan 76 80 830 834 I-treatment

Patients 0 8 835 843 O
with 9 13 844 848 O
active 14 20 849 855 B-chronic_disease
infection 21 30 856 865 I-chronic_disease

Pregnant 0 8 866 874 B-pregnancy
women 9 14 875 880 B-gender

Pre‐treatment 0 13 881 894 B-treatment
laboratory 14 24 895 905 O
criteria 25 33 906 914 O
within 34 40 915 921 O
four 41 45 922 926 O
weeks 46 51 927 932 O
of 52 54 933 935 O
enrollment 55 65 936 946 O

Primary 0 7 947 954 B-cancer
tumor 8 13 955 960 I-cancer
( 14 15 961 962 I-cancer
T4 15 17 962 964 I-cancer
) 17 18 964 965 I-cancer
with 19 23 966 970 O
or 24 26 971 973 O
without 27 34 974 981 O
metastatic 35 45 982 992 B-cancer
lymph 46 51 993 998 I-cancer
nodes 52 57 999 1004 I-cancer

Prior 0 5 1005 1010 B-treatment
head 6 10 1011 1015 I-treatment
and 11 14 1016 1019 I-treatment
neck 15 19 1020 1024 I-treatment
radiation 20 29 1025 1034 I-treatment

Stage 0 5 1035 1040 B-lower_bound
III 6 9 1041 1044 I-lower_bound
/ 9 10 1044 1045 O
IV 10 12 1045 1047 B-lower_bound
oral 13 17 1048 1052 O
cavity 18 24 1053 1059 O
or 25 27 1060 1062 O
paranasal 28 37 1063 1072 B-cancer
sinus 38 43 1073 1078 I-cancer
cancers 44 51 1079 1086 I-cancer
in 52 54 1087 1089 O
patients 55 63 1090 1098 O
who 64 67 1099 1102 O
refuse 68 74 1103 1109 O
surgery 75 82 1110 1117 B-treatment
or 83 85 1118 1120 O
are 86 89 1121 1124 O
unfit 90 95 1125 1130 O
for 96 99 1131 1134 O
surgery 100 107 1135 1142 O

T3 0 2 1143 1145 B-cancer
or 3 5 1146 1148 O
T4 6 8 1149 1151 B-cancer
laryngeal 9 18 1152 1161 I-cancer
or 19 21 1162 1164 O
hypopharyngeal 22 36 1165 1179 B-cancer
cancer 37 43 1180 1186 I-cancer
that 44 48 1187 1191 O
is 49 51 1192 1194 O
locally 52 59 1195 1202 O
advanced 60 68 1203 1211 O

Total 0 5 1212 1217 O
Bilirubin 6 15 1218 1227 B-clinical_variable
< 16 17 1228 1229 O
1.5 18 21 1230 1233 B-upper_bound
X 22 23 1234 1235 I-upper_bound
ULN 24 27 1236 1239 I-upper_bound

bulky 0 5 1240 1245 B-clinical_variable
( 6 7 1246 1247 O
> 7 8 1247 1248 B-lower_bound
40 8 10 1248 1250 I-lower_bound
cc 11 13 1251 1253 I-lower_bound
* 13 14 1253 1254 O
) 14 15 1254 1255 O

non‐metastatic 0 14 1256 1270 B-cancer
locally 15 22 1271 1278 O
/ 22 23 1278 1279 O
regionally 23 33 1279 1289 O
advanced 34 42 1290 1298 B-cancer
squamous 43 51 1299 1307 I-cancer
cell 52 56 1308 1312 I-cancer
carcinoma 57 66 1313 1322 I-cancer
of 67 69 1323 1325 O
the 70 73 1326 1329 O
head 74 78 1330 1334 O
and 79 82 1335 1338 O
neck 83 87 1339 1343 O

patient 0 7 1344 1351 O
refuses 8 15 1352 1359 O
surgery 16 23 1360 1367 B-treatment
, 23 24 1367 1368 O
or 25 27 1369 1371 O
surgery 28 35 1372 1379 O
is 36 38 1380 1382 O
not 39 42 1383 1386 O
possible 43 51 1387 1395 O
due 52 55 1396 1399 O
to 56 58 1400 1402 O
comorbidities 59 72 1403 1416 O

referred 0 8 1417 1425 O
for 9 12 1426 1429 O
definitive 13 23 1430 1440 B-treatment
chemo‐RT 24 32 1441 1449 I-treatment

unresectable 0 12 1450 1462 O
, 12 13 1462 1463 O
or 14 16 1464 1466 O
patient 17 24 1467 1474 O
declines 25 33 1475 1483 O
surgery 34 41 1484 1491 B-treatment

